Dimensional Fund Advisors LP raised its stake in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 18.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,789,996 shares of the company's stock after purchasing an additional 580,323 shares during the period. Dimensional Fund Advisors LP owned 2.33% of Integral Ad Science worth $39,567,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. First Trust Advisors LP lifted its position in shares of Integral Ad Science by 295.6% during the 4th quarter. First Trust Advisors LP now owns 171,378 shares of the company's stock valued at $1,789,000 after acquiring an additional 128,056 shares during the period. PEAK6 LLC bought a new stake in Integral Ad Science during the fourth quarter worth about $146,000. XTX Topco Ltd acquired a new stake in Integral Ad Science during the fourth quarter worth about $172,000. Barclays PLC increased its holdings in Integral Ad Science by 11.3% in the 4th quarter. Barclays PLC now owns 142,137 shares of the company's stock valued at $1,484,000 after buying an additional 14,404 shares during the period. Finally, Quinn Opportunity Partners LLC acquired a new position in shares of Integral Ad Science in the 4th quarter valued at approximately $835,000. Institutional investors and hedge funds own 95.78% of the company's stock.
Insider Buying and Selling at Integral Ad Science
In related news, CEO Lisa Utzschneider sold 8,547 shares of the stock in a transaction dated Monday, April 7th. The shares were sold at an average price of $6.85, for a total value of $58,546.95. Following the completion of the transaction, the chief executive officer now directly owns 341,271 shares of the company's stock, valued at $2,337,706.35. This represents a 2.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders sold 77,855 shares of company stock valued at $574,587 in the last 90 days. Insiders own 2.00% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on the stock. Truist Financial raised their price target on shares of Integral Ad Science from $16.00 to $17.00 and gave the company a "buy" rating in a research note on Monday, March 3rd. Barclays cut their target price on shares of Integral Ad Science from $14.00 to $7.00 and set an "equal weight" rating on the stock in a research report on Monday, April 21st. Stifel Nicolaus lowered their price target on shares of Integral Ad Science from $15.00 to $13.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Raymond James reduced their price objective on Integral Ad Science from $16.00 to $11.00 and set an "outperform" rating on the stock in a research report on Monday. Finally, Benchmark reaffirmed a "hold" rating on shares of Integral Ad Science in a report on Friday, February 28th. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, Integral Ad Science presently has an average rating of "Moderate Buy" and an average target price of $13.15.
Read Our Latest Stock Analysis on Integral Ad Science
Integral Ad Science Trading Down 0.9 %
Integral Ad Science stock traded down $0.07 during mid-day trading on Friday, hitting $7.72. The company's stock had a trading volume of 1,141,562 shares, compared to its average volume of 1,013,087. The business has a 50 day moving average price of $7.92 and a 200-day moving average price of $9.76. Integral Ad Science Holding Corp. has a 12 month low of $6.26 and a 12 month high of $13.62. The stock has a market cap of $1.26 billion, a price-to-earnings ratio of 38.60, a price-to-earnings-growth ratio of 1.06 and a beta of 1.55. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings results on Friday, February 28th. The company reported $0.09 EPS for the quarter, missing analysts' consensus estimates of $0.12 by ($0.03). Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm had revenue of $153.00 million for the quarter, compared to the consensus estimate of $148.83 million. During the same quarter in the prior year, the company earned $0.06 earnings per share. The company's quarterly revenue was up 13.9% compared to the same quarter last year. As a group, analysts forecast that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.
Integral Ad Science Company Profile
(
Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Stories

Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.